Resveratrol-induced autophagocytosis in ovarian cancer cells

被引:325
作者
Opipari, AW
Tan, LJ
Boitano, AE
Sorenson, DR
Aurora, A
Liu, JR
机构
[1] Univ Michigan, Dept Obstet & Gynecol, Div Gynecol Oncol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Chem, Div Gynecol Oncol, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Cell & Dev Biol, Div Gynecol Oncol, Ann Arbor, MI 48109 USA
关键词
D O I
10.1158/0008-5472.CAN-03-2404
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Resveratrol (3,5,4-trihydroxystilbene), a natural phytoalexin present in grapes, nuts, and red wine, has antineoplastic activities. Several molecular mechanisms have been described to underlie its effects on cells in vitro and in vivo. In the present study, the response of ovarian cancer cells to resveratrol is explored. Resveratrol inhibited growth and induced death in a panel of five human ovarian carcinoma cell lines. The response was associated with mitochondrial release of cytochrome c, formation of the apoptosome complex, and caspase activation. Surprisingly, even with these molecular features of apoptosis, analysis of resveratrol-treated cells by light and electron microscopy revealed morphology and ultrastructural changes indicative of autophagocytic, rather than apoptotic, death. This suggests that resveratrol can induce cell death through two distinct pathways. Consistent with resveratrol's ability to kill cells via nonapoptotic processes, cells transfected to express high levels of the antiapoptotic proteins Bcl-x(L) and Bcl-2 are equally sensitive as control cells to resveratrol. Together, these findings show that resveratrol induces cell death in ovarian cancer cells through a mechanism distinct from apoptosis, therefore suggesting that it may provide leverage to treat ovarian cancer that is chemoresistant on the basis of ineffective apoptosis.
引用
收藏
页码:696 / 703
页数:8
相关论文
共 61 条
[1]  
Ahmad N, 2001, CLIN CANCER RES, V7, P1466
[2]   The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway [J].
Arico, S ;
Petiot, A ;
Bauvy, C ;
Dubbelhuis, PF ;
Meijer, AJ ;
Codogno, P ;
Ogier-Denis, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (38) :35243-35246
[3]   Inhibition of cancer growth by resveratrol is related to its low bioavailability [J].
Asensi, M ;
Medina, I ;
Ortega, A ;
Carretero, J ;
Baño, MC ;
Obrador, E ;
Estrela, JM .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 (03) :387-398
[4]  
Banerjee S, 2002, CANCER RES, V62, P4945
[5]   Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells [J].
Bernhard, D ;
Tinhofer, I ;
Tonko, M ;
Hübl, H ;
Ausserlechner, MJ ;
Greil, R ;
Kofler, R ;
Csordas, A .
CELL DEATH AND DIFFERENTIATION, 2000, 7 (09) :834-842
[6]   Cancer chemopreventive activity of resveratrol [J].
Bhat, KPL ;
Pezzuto, JM .
ALCOHOL AND WINE IN HEALTH AND DISEASE, 2002, 957 :210-229
[7]   Biological effects of resveratrol [J].
Bhat, KPL ;
Kosmeder, JW ;
Pezzuto, JM .
ANTIOXIDANTS & REDOX SIGNALING, 2001, 3 (06) :1041-1064
[8]  
Bhat KPL, 2001, CANCER RES, V61, P7456
[9]  
Bhat KPL, 2001, CANCER RES, V61, P6137
[10]  
BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3